Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Zu-Yau Lin

6PUBLICATIONS

13CO-AUTHORS

Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsRespiratory diseases

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Sep 27, 2025

Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine.

Zu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang

|Dec 31, 2024

Safety of transarterial chemoembolization on renal function in combined hepatocellular carcinoma and chronic kidney disease patients.

Zu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang

|Oct 28, 2023

Dose Consideration of Lenvatinib's Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine Therapy.

Zu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang

|Feb 10, 2022

Limited sorafenib anticancer effects on primary cultured hepatocellular carcinoma cells with high NANOG expression.

Zu-Yau Lin, Ming-Lun Yeh, Ching-I Huang

|Oct 23, 2021

The Persistence of Hepatitis C Virus Infection in Hepatocytes Promotes Hepatocellular Carcinoma Progression by Pro-Inflammatory Interluekin-8 Expression.

Ciniso Sylvester Shabangu, Phumelele Yvonne Siphepho, Chia-Yang Li

|Feb 03, 2021

Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group.

Yu-Ju Wei, Po-Yao Hsu, Jia-Jung Lee

Pageof 1

Frequent Collaborators

4 joint publications

Chia-Yen Dai

4 joint publications

Ming-Lung Yu

3 joint publications

Chung-Feng Huang

2 joint publications

Po-Cheng Liang

2 joint publications

Ming-Lun Yeh

2 joint publications

Wan-Long Chuang

2 joint publications

Jee-Fu Huang

1 joint publications

Yu-Ju Wei

1 joint publications

Ciniso Sylvester Shabangu

1 joint publications

Chia-Yang Li

Frequent Collaborators

4 joint publications

Chia-Yen Dai

4 joint publications

Ming-Lung Yu

3 joint publications

Chung-Feng Huang

2 joint publications

Po-Cheng Liang

Top Related Videos

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on : Jul 31, 2016

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on : Sep 12, 2019

See more related videos

Top Related Videos

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on : Jul 31, 2016

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on : Sep 12, 2019

See more related videos